Anuja Chatterjee

1.1k total citations · 1 hit paper
19 papers, 710 citations indexed

About

Anuja Chatterjee is a scholar working on Applied Microbiology and Biotechnology, Genetics and Biomedical Engineering. According to data from OpenAlex, Anuja Chatterjee has authored 19 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Applied Microbiology and Biotechnology, 4 papers in Genetics and 4 papers in Biomedical Engineering. Recurrent topics in Anuja Chatterjee's work include Antibiotic Use and Resistance (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Patient Satisfaction in Healthcare (2 papers). Anuja Chatterjee is often cited by papers focused on Antibiotic Use and Resistance (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Patient Satisfaction in Healthcare (2 papers). Anuja Chatterjee collaborates with scholars based in United Kingdom, United States and India. Anuja Chatterjee's co-authors include Julie V. Robotham, Nichola R. Naylor, Rifat Atun, Sachin Silva, Gwenan M. Knight, Kavian Kulasabanathan, Nina Zhu, James Barlow, Alan P. Johnson and Alison Holmes and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Lancet Infectious Diseases.

In The Last Decade

Anuja Chatterjee

16 papers receiving 695 citations

Hit Papers

Estimating the burden of antimicrobial resistance: a syst... 2018 2026 2020 2023 2018 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anuja Chatterjee United Kingdom 7 300 229 111 108 90 19 710
Nichola R. Naylor United Kingdom 13 418 1.4× 295 1.3× 124 1.1× 177 1.6× 117 1.3× 33 999
Alan D Lopez Philippines 6 236 0.8× 199 0.9× 124 1.1× 120 1.1× 178 2.0× 22 882
Nithima Sumpradit Thailand 10 210 0.7× 160 0.7× 118 1.1× 70 0.6× 54 0.6× 12 608
Katie K Tseng United States 9 372 1.2× 207 0.9× 82 0.7× 172 1.6× 114 1.3× 14 742
Hannah Wolford United States 8 212 0.7× 283 1.2× 116 1.0× 148 1.4× 47 0.5× 23 740
Xuemei Zhen China 15 185 0.6× 244 1.1× 168 1.5× 130 1.2× 52 0.6× 46 970
Babatunde Olubajo United States 10 150 0.5× 245 1.1× 133 1.2× 143 1.3× 54 0.6× 20 750
Scott Kaba Matafwali Zambia 16 254 0.8× 180 0.8× 87 0.8× 63 0.6× 65 0.7× 38 650
Kavian Kulasabanathan United Kingdom 5 190 0.6× 154 0.7× 70 0.6× 68 0.6× 42 0.5× 8 455
Sachin Silva United States 10 191 0.6× 155 0.7× 81 0.7× 122 1.1× 39 0.4× 13 674

Countries citing papers authored by Anuja Chatterjee

Since Specialization
Citations

This map shows the geographic impact of Anuja Chatterjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anuja Chatterjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anuja Chatterjee more than expected).

Fields of papers citing papers by Anuja Chatterjee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anuja Chatterjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anuja Chatterjee. The network helps show where Anuja Chatterjee may publish in the future.

Co-authorship network of co-authors of Anuja Chatterjee

This figure shows the co-authorship network connecting the top 25 collaborators of Anuja Chatterjee. A scholar is included among the top collaborators of Anuja Chatterjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anuja Chatterjee. Anuja Chatterjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bag, Neelanjana, Jhilik Roy, Anuja Chatterjee, et al.. (2025). Piezoelectric barium titanate/ PVDF-HFP nanocomposite-mediated soft ultrasound assisted organic dye degradation and antibacterial therapy against Bacillus subtilis and Vibrio cholerae. Materials Today Sustainability. 30. 101102–101102. 2 indexed citations
3.
Kessel, Robin van, Elías Mossialos, Victoria Saint, et al.. (2025). Mapping socioeconomic factors driving antimicrobial resistance in humans: An umbrella review. One Health. 20. 100986–100986. 4 indexed citations
4.
Chatterjee, Anuja, Neelanjana Bag, Somsuvra Banerjee, et al.. (2025). Advanced Photo‐Responsive (II‐VI) Semiconductor Nanoparticle for Efficient Elimination of Carcinogenic Dye and Waterborne Pathogens. ChemistrySelect. 10(21). 2 indexed citations
6.
Chatterjee, Anuja, Neelanjana Bag, Somsuvra Banerjee, et al.. (2025). Fabrication of Biocompatible and Antimicrobially Active ZnO‐Chitosan Nanocomposite Thin Film: A Smart Approach for Active Food Packaging. ChemistrySelect. 10(36).
7.
Mondal, Indrajit, Neelanjana Bag, T. Hassan, et al.. (2024). ZrO2 nanoparticle embedded reusable and self-standing biopolymeric membrane for efficient piezodynamic eradication of gram-positive and gram-negative coliform bacteria. Colloids and Surfaces A Physicochemical and Engineering Aspects. 705. 135546–135546. 3 indexed citations
8.
Mondal, Indrajit, Anuja Chatterjee, Neelanjana Bag, et al.. (2024). Crystal growth mediated physicochemical properties enhancement of CoMnO3 perovskite nanomaterials and its efficient degradation of organic dyes and pathogenic bacteria under mechanical stimuli. Journal of environmental chemical engineering. 12(2). 112385–112385. 17 indexed citations
10.
Chatterjee, Anuja, Ron Goeree, Carolyn Owen, et al.. (2022). A Probabilistic Cost-Effectiveness Analysis of Venetoclax and Obinutuzumab as a First-Line Therapy in Chronic Lymphocytic Leukemia in Canada. PharmacoEconomics - Open. 7(2). 199–216. 6 indexed citations
11.
Chatterjee, Anuja, Sheila Shapouri, Beenish S. Manzoor, et al.. (2021). Cost-effectiveness of a 12-month fixed-duration venetoclax treatment in combination with obinutuzumab in first-line, unfit chronic lymphocytic leukemia in the United States. Journal of Managed Care & Specialty Pharmacy. 27(11). 1532–1544. 14 indexed citations
12.
Chatterjee, Anuja, et al.. (2020). The costs of treating vaginal and vulval cancer in England (2009–2015). BMC Public Health. 20(1). 453–453. 3 indexed citations
14.
Chatterjee, Anuja, et al.. (2019). Antibiotics as feed additives for livestock: Human health concerns. Indian Journal of Animal Health. 58(2-SPL). 121–121. 23 indexed citations
15.
Davids, Matthew S., Anuja Chatterjee, Arliene Ravelo, et al.. (2019). Cost-Effectiveness of a 12-Month Fixed Duration of Venetoclax in Combination with Obinutuzumab in First-Line Chronic Lymphocytic Leukemia in the United States. Blood. 134(Supplement_1). 4741–4741. 7 indexed citations
16.
Chatterjee, Anuja, M Modarai, Nichola R. Naylor, et al.. (2018). Quantifying drivers of antibiotic resistance in humans: a systematic review. The Lancet Infectious Diseases. 18(12). e368–e378. 234 indexed citations
17.
Naylor, Nichola R., Rifat Atun, Nina Zhu, et al.. (2018). Estimating the burden of antimicrobial resistance: a systematic literature review. Antimicrobial Resistance and Infection Control. 7(1). 58–58. 387 indexed citations breakdown →
18.
Naylor, Nichola R., Ijeoma Uchegbu, Anuja Chatterjee, & Julie V. Robotham. (2017). Gambling with antibiotics: a novel approach for exploring antibiotic consumption decision-making. Public Health. 151. 146–148. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026